By Maxx Chatsko The drug developer’s latest capital raise, a $150 million private placement, comes during a difficult market environment. The strongest companies can raise money in any environment. Recursion Pharmaceuticals (RXRX) – Get Recursion Pharmaceuticals Inc. Report recently raised $150 million in gross proceeds from a private placement of common stock, including half from a single fund that has never before invested in the company. A private placement means all shares were sold directly to investment funds rather than offered to the public. Such transactions typically occur at more fa…